Literature DB >> 22711554

Quiescence and attenuated DNA damage response promote survival of esophageal cancer stem cells.

Yulin Chen1, Dan Li, Dapeng Wang, Xuefeng Liu, Ning Yin, Yongmei Song, Shih Hsin Lu, Zhenyu Ju, Qimin Zhan.   

Abstract

Accumulating evidence indicates cancer stem cells (CSCs) possess the capability to resist DNA-damage induced cell death, whereas the mechanism is largely unknown. Here we show that cell cycle status and DNA damage response (DDR) in CSCs probably contribute to their survival in genotoxic insults. In this study, we isolated esophageal cancer stem cells (ECSCs) from esophageal cancer cell line EC9706 by side-population (SP) phenotype through flow cytometry and found that ECSCs preferentially stay quiescent as compared to the non-ECSCs and are more resistant to DNA damage agents. Further study revealed that ECSCs express a lower level of EGFR, phosphoralated Stat3, and c-Myc, yet abnormally upregulated p27. More interestingly, different from non-ECSCs, when suffering DNA damage agents, ECSCs showed attenuated DDR, as well as declined DNA repair potential. These data indicated ECSCs probably employed an impaired DDR to handle severe genomic insults. Conclusively, we infer that the damage-resistance ability of ECSCs is likely attributed to their slow-cycling status and avoidance of apoptosis or senescence triggered by an excessive DDR.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22711554     DOI: 10.1002/jcb.24228

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  15 in total

1.  Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response.

Authors:  Ayala Gold; Lital Eini; Malka Nissim-Rafinia; Ruth Viner; Shlomit Ezer; Keren Erez; Nasma Aqaqe; Rotem Hanania; Michael Milyavsky; Eran Meshorer; Michal Goldberg
Journal:  Oncogene       Date:  2019-01-08       Impact factor: 9.867

Review 2.  The mechanisms of radioresistance in esophageal squamous cell carcinoma and current strategies in radiosensitivity.

Authors:  Guang-Zong Chen; Hong-Cheng Zhu; Wang-Shu Dai; Xiao-Ning Zeng; Jin-Hua Luo; Xin-Chen Sun
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 3.  Therapeutic targeting of gastrointestinal cancer stem cells.

Authors:  Jonathan Stem; John C Flickinger; Dante Merlino; Ellen M Caparosa; Adam E Snook; Scott A Waldman
Journal:  Regen Med       Date:  2019-04-26       Impact factor: 3.806

4.  Time-lapse microscopic observation of non-dividing cells in cultured human osteosarcoma MG-63 cell line.

Authors:  John Dosch; Elise Hadley; Cal Wiese; Marissa Soderberg; Tori Houwman; Kai Ding; Alexandra Kharazova; John L Collins; Bart van Knippenberg; Carl Gregory; Alexander Kofman
Journal:  Cell Cycle       Date:  2017-12-26       Impact factor: 4.534

Review 5.  Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?

Authors:  Qian Zhang; Yunjiang Feng; Derek Kennedy
Journal:  Cell Mol Life Sci       Date:  2016-09-12       Impact factor: 9.261

6.  DNA damage responses in cancer stem cells: Implications for cancer therapeutic strategies.

Authors:  Qi-En Wang
Journal:  World J Biol Chem       Date:  2015-08-26

Review 7.  Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitors.

Authors:  Christine Victoria Ichim
Journal:  Stem Cells Transl Med       Date:  2014-03-05       Impact factor: 6.940

8.  Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis.

Authors:  Xiao-Ming Du; Liu-Hua Wang; Xiao-Wen Chen; Yi-Xiao Li; Yu-Cong Li; Yu-Wen Cao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

9.  HIV-1 Vpr- and Reverse Transcription-Induced Apoptosis in Resting Peripheral Blood CD4 T Cells and Protection by Common Gamma-Chain Cytokines.

Authors:  Benjamin Trinité; Chi N Chan; Caroline S Lee; David N Levy
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

10.  Curcumin Improves the Tumoricidal Effect of Mitomycin C by Suppressing ABCG2 Expression in Stem Cell-Like Breast Cancer Cells.

Authors:  Qianmei Zhou; Meina Ye; Yiyu Lu; Hui Zhang; Qilong Chen; Shuang Huang; Shibing Su
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.